- Home
- DAKT vs INM Comparison
DAKT vs INM Comparison
Compare DAKT & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAKT
- INM
- Stock Information
- Founded
- DAKT 1968
- INM 1981
- Country
- DAKT United States
- INM Canada
- Employees
- DAKT N/A
- INM N/A
- Industry
- DAKT Office Equipment/Supplies/Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- DAKT Industrials
- INM Health Care
- Exchange
- DAKT Nasdaq
- INM Nasdaq
- Market Cap
- DAKT 710.0M
- INM 3.2M
- IPO Year
- DAKT 1994
- INM N/A
- Fundamental
- Price
- DAKT $15.33
- INM $3.32
- Analyst Decision
- DAKT Strong Buy
- INM
- Analyst Count
- DAKT 1
- INM 0
- Target Price
- DAKT $26.00
- INM N/A
- AVG Volume (30 Days)
- DAKT 498.3K
- INM 9.5M
- Earning Date
- DAKT 06-25-2025
- INM 05-12-2025
- Dividend Yield
- DAKT N/A
- INM N/A
- EPS Growth
- DAKT N/A
- INM N/A
- EPS
- DAKT N/A
- INM N/A
- Revenue
- DAKT $756,477,000.00
- INM $4,920,990.00
- Revenue This Year
- DAKT N/A
- INM N/A
- Revenue Next Year
- DAKT $4.86
- INM N/A
- P/E Ratio
- DAKT N/A
- INM N/A
- Revenue Growth
- DAKT N/A
- INM N/A
- 52 Week Low
- DAKT $10.24
- INM $1.72
- 52 Week High
- DAKT $19.89
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- DAKT 62.88
- INM 59.24
- Support Level
- DAKT $13.30
- INM $2.26
- Resistance Level
- DAKT $16.04
- INM $5.50
- Average True Range (ATR)
- DAKT 0.59
- INM 0.40
- MACD
- DAKT 0.15
- INM 0.11
- Stochastic Oscillator
- DAKT 88.32
- INM 37.04
About DAKT Daktronics Inc.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.